« Will Bombardier’s Smooth Ride Last? | Inicio | bbcbusiness: What is the secret behind Google’s huge success? http://tinyurl.com/5ekxnx »
Pfizer Awaits Fablyn Probe
By Anita Broker | September 4, 2008
On Monday, the FDA will say if the pharma’s osteoporosis drug has more pros than cons.
forbes.com/markets/2008/09/04/pfizer-ligand-closer-markets-equity
Categoría: Forbes: Markets News |